Centre for Inflammation Biology and Cancer Immunology, The Peter Gorer Department of Immunobiology, School of Immunology & Microbial Sciences, King's College London, London, UK; Cancer Research UK King's Health Partner Cancer Centre, King's College London, London, UK.
PSL Research University, Institut Curie Research Center, Translational Immunotherapy Team, INSERM U932, Paris, France.
Immunity. 2020 Aug 18;53(2):335-352.e8. doi: 10.1016/j.immuni.2020.06.002. Epub 2020 Jun 30.
Dendritic cells (DCs) are antigen-presenting cells controlling T cell activation. In humans, the diversity, ontogeny, and functional capabilities of DC subsets are not fully understood. Here, we identified circulating CD88CD1cCD163 DCs (called DC3s) as immediate precursors of inflammatory CD88CD14CD1cCD163FcεRI DCs. DC3s develop via a specific pathway activated by GM-CSF, independent of cDC-restricted (CDP) and monocyte-restricted (cMoP) progenitors. Like classical DCs but unlike monocytes, DC3s drove activation of naive T cells. In vitro, DC3s displayed a distinctive ability to prime CD8 T cells expressing a tissue homing signature and the epithelial homing alpha-E integrin (CD103) through transforming growth factor β (TGF-β) signaling. In vivo, DC3s infiltrated luminal breast cancer primary tumors, and DC3 infiltration correlated positively with CD8CD103CD69 tissue-resident memory T cells. Together, these findings define DC3s as a lineage of inflammatory DCs endowed with a strong potential to regulate tumor immunity.
树突状细胞 (DCs) 是控制 T 细胞激活的抗原呈递细胞。在人类中,DC 亚群的多样性、发生和功能能力尚未完全了解。在这里,我们鉴定出循环 CD88CD1cCD163 DC (称为 DC3)是炎性 CD88CD14CD1cCD163FcεRI DC 的直接前体。DC3 通过 GM-CSF 激活的特定途径发育,独立于 cDC 限制(CDP)和单核细胞限制(cMoP)祖细胞。与经典 DC 不同,但与单核细胞不同,DC3 驱动幼稚 T 细胞的激活。在体外,DC3 通过转化生长因子 β(TGF-β)信号显示出独特的能力,可启动表达组织归巢特征和上皮归巢α-E 整合素 (CD103) 的 CD8 T 细胞。在体内,DC3 浸润管腔乳腺癌原发性肿瘤,并且 DC3 浸润与 CD8CD103CD69 组织驻留记忆 T 细胞呈正相关。总之,这些发现将 DC3 定义为具有强大调节肿瘤免疫潜力的炎性 DC 谱系。